Hong Kong biotech company Prenetics will go public through a merger agreement with Artisan Acquisition, a special purpose acquisition company (SPAC), valuing the combined company at $1.7 billion, they said in a...
Sanofi makes $3.2 billion offer for U.S. mRNA partner Translate Bio
Sanofi said on Tuesday it has made a $3.2 billion offer to buy U.S. biotech company Translate Bio, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race, confirming a Reuters...
Dr Reddy’s partners Fujifilm to launch Avigan for Covid-19 treatment
Indian generic drug maker Dr Reddy’s Laboratories has partnered with the Japanese pharma giant Fujifilm Toyama Chemical and Global Response Aid (GRA) for development, manufacture and sale of antiviral drug Avigan...
GSK, Sanofi team up to bring out Covid-19 vaccine
Two of the world’s largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a COVID-19 vaccine, which if it passes the clinical trials would become available by 2021. Sanofi and...
BioNTech hires banks for IPO worth up to $800 million: sources
BioNTech, Europe’s largest unlisted biotech firm by staff numbers, has hired banks to prepare for an initial public offering (IPO) worth as much as $800 million as early as this year, people familiar with the plan told...
ICMR partners with IVI, invests Rs 3.20 crore for vaccine development in India
The Indian Council of Medical Research (ICMR) has entered into an agreement to collaborate on vaccine research and development with international vaccine development organisation International Vaccine Institute (IVI)...
Serum Institute buys defunct Czech vaccine maker for €72 million
Serum Institute of India Ltd, the world’s largest vaccine maker by number of doses produced and sold, has acquired a defunct unit of Czech Republic-based injectable polio doses maker Nanotherapeutics Inc. for €72...
Panacea picks up 10% in UK firm
Panacea picks up 10% in UK firm Panacea Biotec has picked up 10 per cent stake in its long-term UK-based technology partner Cambridge Biostability (CBL) for £ 1.93 million. The two companies have also signed a...
Panacea Biotec acquires 10 pc stake in UK co
Panacea Biotec acquires 10 pc stake in UK co Panacea Biotec Ltd has acquired a 10 per cent in UK-based liquid vaccine developer Cambridge Biostability Ltd (CBL) for around Rs 17 crore (£1.935million) through a...
Panacea Biotec & Cambridge Biostability, UK sign Joint Venture & licensing Agreement
Panacea Biotec & Cambridge Biostability, UK sign Joint Venture & licensing Agreement Panacea Biotec Ltd has informed BSE that, Cambridge Biostability Ltd ("CLB" or "Cambridge Biostability")...
Cadila forms JV with US-based vaccine major Novavax
Ahmedabad-based Rs 800-crore Cadila Pharmaceuticals Ltd is all geared up for a large pie in the $665-million vaccine market in India. On Thursday, it formally announced a joint venture with US-based vaccine...
Pharma is a Sweet-Spot in Global Acquisitions in 2015
The year 2015 created a record in terms of global mergers and acquisitions (M&As). The total value touched $5.03 trillion, a massive rise of 37% ($3.67 trillion) from 2014, according to data from Dealogic...